More on AORT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-95.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Artivion (NY:AORT)
Delayed: 25.06 -0.67 (2.6%)
Prev. Close $25.73  
Open$25.45 
52 Wk High$ 
52 Wk Low$ 
Day High$25.85 
Day Low$24.79 
P/E N/A  
EPS$ 
Volume535,320 


Jun 29, 2026 09:12 AM Canaccord Reiterates Buy Rating on Artivion Inc. (AORT)
Jun 29, 2026 07:02 AM FDA approves Artivion's AMDS device for aortic dissection treatment
Jun 29, 2026 07:00 AM Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
Jun 16, 2026 06:36 AM Canaccord Reiterates Buy Rating on Artivion Inc. (AORT)
Jun 15, 2026 11:29 AM Form 4 ARTIVION, INC. For: Jun 11 Filed by: GREEN ANDREW M
Jun 11, 2026 04:50 PM Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M
Jun 10, 2026 04:10 PM Artivion to Participate in the 2026 Truist Securities MedTech Conference
Jun 8, 2026 05:51 PM Form 3 ARTIVION, INC. For: Jun 01 Filed by: GREEN ANDREW M
Jun 4, 2026 04:50 PM Form 4 ARTIVION, INC. For: Jun 02 Filed by: SEMEDO ANTHONY B.
Jun 1, 2026 07:29 AM Stifel Reiterates Buy Rating on Artivion (AORT)
View All Articles

Entities mentioned with AORT

View All Entities